(19)

(11)

EP 3 946 392 A1

(12)

(43) Date of publication: 09.02.2022 Bulletin 2022/06 (21) Application number: 20776481.2 (22) Date of filing: 29.03.2020

(51) International Patent Classification (IPC):  A61K 35/741(2015.01) A61K 35/745(2015.01) C12N 1/20(2006.01) A61K 35/747(2015.01) A61P 1/00(2006.01) (52) Cooperative Patent Classification (CPC): C12N 1/20; A61K 35/747; A61K 35/745; A61K 35/741; A61P 1/00; C12R 2001/225; C12N 1/205; C12R 2001/01 (86) International application number: PCT/IL2020/050380 (87) International publication number: WO 2020/194319 (01.10.2020 Gazette 2020/40)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 28.03.2019 US 201916368030 02.04.2019 US 201962827931 P (71) Applicant: Mybiotics Pharma Ltd 7608804 Rehovot (IL)	(72) Inventor: ELIYAHU, Hila 9728166 Jerusalem (IL) (74) Representative: Boult Wade Tennant LLP  Salisbury Square House 8 Salisbury Square London EC4Y 8AP London EC4Y 8AP (GB)